Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VAISHALI PHARMA    ADCOCK INGRAM
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
VAISHALI PHARMA /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs194320-   
Low Rs64231-   
Sales per share (Unadj.) Rs66.095.1-  
Earnings per share (Unadj.) Rs6.3-24.0-  
Cash flow per share (Unadj.) Rs6.7-19.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.374.6-  
Shares outstanding (eoy) m10.55168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.9 67.5%   
Avg P/E ratio x20.6-11.5 -179.5%  
P/CF ratio (eoy) x19.1-13.9 -138.2%  
Price / Book Value ratio x4.13.7 112.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,36146,446 2.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m132,915 0.4%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m69716,052 4.3%  
Other income Rs m22112 19.8%   
Total revenues Rs m71916,165 4.4%   
Gross profit Rs m94-2,782 -3.4%  
Depreciation Rs m5693 0.7%   
Interest Rs m23435 5.2%   
Profit before tax Rs m88-3,797 -2.3%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m22237 9.5%   
Profit after tax Rs m66-4,045 -1.6%  
Gross profit margin %13.5-17.3 -77.7%  
Effective tax rate %25.4-6.2 -405.7%   
Net profit margin %9.5-25.2 -37.6%  
BALANCE SHEET DATA
Current assets Rs m72711,757 6.2%   
Current liabilities Rs m3216,615 4.8%   
Net working cap to sales %58.332.0 182.0%  
Current ratio x2.31.8 127.5%  
Inventory Days Days18111 16.2%  
Debtors Days Days2,809124 2,266.4%  
Net fixed assets Rs m616,853 0.9%   
Share capital Rs m10575 141.5%   
"Free" reserves Rs m2240-   
Net worth Rs m33012,599 2.6%   
Long term debt Rs m524,428 1.2%   
Total assets Rs m78823,801 3.3%  
Interest coverage x4.9-7.7 -63.6%   
Debt to equity ratio x0.20.4 45.1%  
Sales to assets ratio x0.90.7 131.2%   
Return on assets %11.2-15.2 -74.2%  
Return on equity %20.0-32.1 -62.4%  
Return on capital %29.1-19.8 -146.7%  
Exports to sales %25.20-   
Imports to sales %7.80-   
Net fx Rs m1210-   
CASH FLOW
From Operations Rs m111,370 0.8%  
From Investments Rs m3-421 -0.7%  
From Financial Activity Rs m-174,018 -0.4%  
Net Cashflow Rs m-44,968 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare VAISHALI PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare VAISHALI PHARMA With: RAJNISH WELLNESS  LINK PHARMA  GUJ.INJ(KER)  NUTRAPLUS PR  SMRUTHI ORGANICS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.